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SUMMARY
The cytolytic activity ofhuman peripheral blood monocytes in vitro against K-562 human
leukaemic target cells was stimulated by human fibroblast (fi-) and leucocyte (a-)
interferon (IFN). Stimulation was by up to several times the corresponding control
activity, and was observed with freshly isolated monocytes, and with monocytes cultured
for various periods up to 10 days. The cytolytic activity of untreated monocytes was
detectable at very low effector: target ratios ( < 5: 1), and fell between days 1 and 4 in
culture, normally rising again towards the initial activity at day 8; this pattern was also
observed when IFN was present continuously, although the activities were then always
higher than in the corresponding control cells. Cytolysis showed a lag of about 6 hr, in
contrast to that by natural killer (NK) cells, and was routinely measured over 24 hr. The
course of stimulation by IFN and its dose-response were studied. Stimulation required
the presence of IFN for at least 24 hr, and was maximal with between 1,000 and 10,000
units of IFN/ml. When IFN containing media were removed and replaced with control
media, the monocyte activity remained stimulated for at least 4 days. Stimulation by
fl-IFN was blocked by a specific antibody to fl-IFN, under conditions in which assayable
IFN activity was also neutralized. Several control experiments indicated that the action of
IFN was on the monocytes and not on the target cells. The morphological maturation of
monocytes was retarded by IFN, even in cultures containing up to 50% serum. The
effectiveness of fibroblast IFN indicated that stimulation could not be attributed to the
lymphokines which might contaminate a-IFN. The action of IFN did not require
simultaneous or antecedent in vitro stimulation by endotoxin. This was indicated both by
serum free experiments, and also by others in which polymixin B was used to complex with
and render unavailable any endotoxin present. Endotoxin showed an independent
stimulatory effect, which could be prevented by polymixin.
INTRODUCTION
Interferon (IFN) is well known to activate mononuclear phagocytes in several respects (Nelson,
1976; Forster & Landy, 1981). Perhaps the most notable amongst these are spreading, Fc receptor
expression, phagocytosis and tumoricidal activity (Schultz, Chirigos & Heine, 1978; Boraschi &
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Tagliabue, 1981). IFN can also restrict virus growth in macrophages (Virelizier, Allison &
DeMaeyer, 1977).
More recently IFN has been frequently reported to positively regulate cytolytic activity of
natural killer (NK) cells in vivo and in vitro (Bloom, 1980; Vilcek, Gresser & Merigan, 1980). In
addition there is evidence that freshly isolated human peripheral blood monocytes possess cytolytic
activity which is somewhat selective for transformed cells (Hammerstrom, 1981) and particularly
effective against adherent cells (Gerrard, Terz& Kaplan, 1980). This activity of fresh monocytes can
be stimulated by IFN (Jett, Mantovani & Herberman, 1980). The cytolytic activity of monocytes
declines in culture, at least up to 2 days (Hammerstrom, 1979a). This decline parallels the
morphological and functional 'maturation' (including cell expansion, and increased vacuolation
and lysosomal enzyme activities: Lee & Epstein, 1980) which the monocytes undergo during this
period. Since IFN has been found to retard both the morphological and biochemical in vitro
maturation of monocytes (Lee & Epstein, 1980), it was the purpose of the present investigation to
study cytolytic activity of monocytes during prolonged in vitro cultivation in its presence. It was
anticipated that IFN might stimulate cytolysis mediated by both fresh and matured monocytes, and
this proved to be the case.
Two other questions were immediately relevant. Firstly, it was necessary to consider the role of
possible contaminants in the IFN preparations. Since lymphokines are also known to stimulate
monocyte cytolysis (Hammerstrom, 1979a), we used both leucocyte IFN (which may be
contaminated with lymphokines) and also fibroblast IFN (which should not be). In addition we
provide evidence that IFN was the active factor in the fibroblast IFN preparations by experiments
with an inhibitory antibody to IFN.
Secondly, since bacterial endotoxin (lipopolysaccharide, LPS) is also a potent acute stimulator
of monocyte cytolytic activity (Hammerstrom, 1979b) we examined its role as a simultaneous or
antecedent co-stimulator with IFN.
MATERIALS AND METHODS
Materials. Human 'buffy coat' residues from single donors were obtained from the Blood
Transfusion units at Hopital Necker, Hopital St Antoine & Centre National de Transfusion
Sanguin.
Human a-IFN was Sendai-induced human leucocyte IFN (Institut Pasteur, Paris) in ampoules
containing 106 international units (iu) of IFN in 1 ml; it was stored at 4°C.
Human fl-IFN was poly-IC-induced human fibroblast IFN, from the Rega Institute, Louvain,
Belgium, in ampoules containing 5 x 106iu of IFN in I ml.; storage was at -200C.
Rabbit antiserum to human fl-IFN, a kind gift from Dr Billiau, Rega Institute, Louvain, was
found to have a titre of 75,000 against 24 iu of human fl-IFN, but had no neutralizing activity
against human x- or y-IFN.
Culture media and sera were from Eurobio, Paris & GIBCO (fetal calf serum, FCS, batch
L2911020D) respectively. Ficoll was from Pharmacia. Endotoxin (LPS) was LPS W (E. Coli
0111: B4) from DIFCO (batch 652888). Polymyxin B sulphate was from Pfizer, Paris. Bovine serum
albumin (BSA) was from Sigma, and the antibody to it was a kind gift of T. Pham Hu, Unite
d'Immunohematologie, Hopital des Enfants Malades. 5'Cr was obtained weekly. Other reagents
were of the highest quality commercially available.
Isolation of monocytes from buffy coats from single donors. This was performed as described
previously (Taichman, Dean & Sanderson, 1980), using dextran sedimentation to remove
erythrocytes, Ficoll gradients to obtain a mononuclear cell band, and selective adherence to obtain
a monocyte rich population of cells. Adherence was normally in RPMI 1640 medium without
serum, and with antibiotics (penicillin 100 iu/ml & streptomycin 100 mg/ml), for 1 hr, and was
followed by four washes with Hank's balanced salt solution (HBSS) and overnight culture with
RPMI without serum. Purity was then 85-95%. The medium was then changed to RPMI/10%
heat-inactivated fetal calf serum (HIFCS) and cells matured after 4 days were > 95% monocytes.
For higher purity of fresh cells, adherence was in the additional presence of 10% HIFCS (Johnson,
502
Interferon as a macrophage activating factor 503
Mei & Cohn, 1977). Purity was judged by morphology, latex phagocytosis in 4 hr, Giemsa staining,
and in some experiments by non-specific esterase staining. Viability was always > 90% asjudged by
trypan blue exclusion.
Cultivation of monocytes. Two different systems were used. In the first ('system 1'), 0-2 ml
mononuclear cells (2 5 x 106/ml) was placed in each well of a flat bottomed Falcon 96 Multiwell
plate (Microtest 2, 3042, Falcon, California, USA). After adherence (day '0') cells were gently
washed with HBSS. Each wash comprised removing the medium, replacing it once and removing it
again. Cells were kept overnight in fresh medium of the same constitution as that in which
adherence had proceeded, and then the medium was changed the next morning (day '0').
Subsequent medium changes were at day 5, then at 2 day intervals, except were experiments
required earlier medium changes. Unless otherwise stated, the media subsequently comprised
RPMI/10% HIFCS with antibiotics.
In system I there was a progressive and variable loss of cells (up to 30% loss by day 5 as also
reported by Johnson et al., 1977), so that when target cells were added at various subsequent times
the effector cell: target cell ratio varied from culture to culture. The numbers of cells remaining in
certain experiments were determined by counting defined areas. The loss of cells was not affected by
the presence of up to 2,500 iu/ml IFN (leucocyte or fibroblast). In general, system 1 gave < 7 x 104
monocytes/culture at day 0 (after washing), and < 5 x 104 at day 5 (after the day 5 medium
change).
To avoid the problem of variability of monocyte number entailed by system 1, a larger scale
cultivation system ('system 2') was also used. Whereas in system 1 cells remained in situ for the
cytolysis assay, in system 2 they were harvested and then aliquoted at standard concentrations into
the cytolysis plates. Thus in system 2, adherence was in 6 cm diameter culture dishes (8 ml of
mononuclear cells at 2 5 x 106/ml), followed by four washes with HBSS. Subsequent cultivation was
as described for system 1. In both systems, cultures were maintained at 370C in a humidified
incubator gassed with 5% CO2 in air.
Maintenance and labelling of target cells. K-562 cells, which are malignant erythro- and
myelopoietic human stem cells, were grown in RPMI/10% HIFCS with antibiotics, in 75 cm2
Falcon flasks. They were subcultivated every 2 days. Cells for use in a cytolysis assay were
centrifuged and incubated at 3-5 x 106 cells/ml with 100 uCi/ml 51Cr, for 1 hr at 37 C. After this they
were washed three times, incubated for 15 min in medium and washed once more. They were then
counted and added to cytolysis assays.
Assay ofcytolysis. With system 1 monocytes, target cells were added in situ into a final volume of
medium of 200 or 250 pl, containing 10% HIFCS. System 2 monocytes were resuspended by
scraping with a rubber policeman, counted and adjusted to 106 trypan blue excluding cells per ml.
One hundred microlitres of the suspension was dispensed into each well of a microtitre plate before
addition of targets (in a further 100 p1). The vast majority ofmonocytes were adherent within I hr of
dispensing.
After incubation for 24 hr (except where otherwise stated), all the cells were in proximity to the
plastic base, and the cell free supernatant was sampled directly for released 51Cr. Experiments
routinely included targets alone ('spontaneous release') at 5 x 103, 104 and 5 x I04 cells/ml in
quadruplicate. Spontaneous release was measured for every duration ofcytolysis used; after 24 hr it
was never more than 20%. Monocyte mediated % specific release was computed as:
100 x (released chromium of monocytes -release by targets alone)
(0 85 x total radioactivity in system) -(release by targets alone)
Eighty-five percent of the total radioactivity in the system was taken as the maximum amount
releasable, since this was the maximum released by Triton (0-1%), 0 5 N NaOH or 0-5 N HCI.
Cell-mediated release never reached this level. As noted in many previous studies, the absolute
number of cells killed was a complex function of the number of targets presented; the modifying
effects of IFN were nevertheless qualitatively consistent.
Reproducibility of replicate assays in system 2 was good (s.d. < 9% of the mean for n = 4); in
system 1, variation of effector cell numbers in the culture wells, especially after prolonged culture,
contributed additional variability (s.d. < 31% of the mean for n = 4). Standard deviation bars are
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shown on the figures, except where they are smaller than the symbol. There were pronounced
quantitative differences in the behaviour of different preparations of monocytes from different
individuals, as often described in the literature; and unlike the behaviour of mouse peritoneal
macrophages pooled from many animals. The qualitative features described here were consistent
however; and every experiment was conducted on cells from at least two different buffy coats, and at
least twice with each culture system.
Assay of interferon activity. Anti-viral activity titration was performed as previously described
(Virelizier, Lenoir & Griscelli, 1978) with slight modifications. The IFN titre was the reciprocal of
the last dilution of the suspension tested that protected 50% of the cultures of MRC-5 human
fibroblasts against the cytopathic effect of 100 infectious doses of a cloned variant of vesicular
stomatitis virus giving large plaques (a kind gift from Dr J. C. Guillon, Institut Pasteur, Paris) in
microplates (Falcon). One unit in our tests was equivalent to 1 international unit as judged by the
standard IFN reference 67/87 (National Institute for Biological Standards and Control, London).
The anti-viral activity of the samples was measured both before and at the conclusion of this work.
Values given in this paper are based on the later assays, and thus may slightly (<25%)
underestimate the activities present in the experiments.
RESULTS
Characterization of the assay and the target cells
The effect of the presence of endotoxin (1-10 ng/ml, 10-100 ig/ml) and IFN (both leucocyte and
fibroblast: 100-12,500 iu/ml) on spontaneous release in 24 hr of 5'Cr from pre-labelled target K-562
cells (104/culture) in the absence of monocytes, was first studied. No significant effects were
detected.
In other experiments, K-562 cells were pre-incubated in normal subculture conditions with 840
iu/ml fl-IFN or without IFN, and then labelled and used in cytolysis assays with normal fresh
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Fig. 1. The kinetics ofcytolysis ofK562 cells by human monocytes. Human monocytes on day 3 ofcultivation by
system 1 (described in Methods) received 104 K-562 targets in Falcon multiwell plates. Control cells were in the
medium described in Methods, and IFN treated received 840 iu/ml of,B-IFN. Chromium release at 0 time and
after 4 hr of incubation was measured after centrifuging the plates (2,000 g for 10 min) to ensure that both
effector and target cells were excluded from the sampled supernatant. This was unnecessary at later times; at
which centrifugation was without effect on the measurements.
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monocytes. Cytolysis was not significantly affected by this manoeuvre. Together, these preliminary
experiments indicate that the effects of IFN reported subsequently are likely to operate on the
monocytes rather than the target cells. In some experiments polymixin B increased 'spontaneous
release' slightly, but this was not studied in detail.
Release from pre-labelled K-562 cells loaded onto the residue of layers of fresh monocytes killed
by freezing and thawing four times was also compared with control spontaneous release. An
inhibition of up to 20% by the monocyte material was observed with 103 targets/culture. This may
have been due to physical entrapping of isotope, or to stabilization of the K-562 cells by the
membraneous debris: similar stabilization has been reported previously. Because of these
considerations target cell numbers of 5 x 103-5 x 104 were used even though with system 1 this did
not permit a high effector: target ratio.
The kinetics of cytolysis by monocytes were also studied (Fig. 1). There was a lag of
approximately 6 hr before significant specific release was detected; after this lag, cytolysis could be
detected in 2 hr periods. This lag was not clearly altered by the presence of IFN during cytolysis,
although the subsequent extent of cytolysis was increased. The kinetics of cytolysis by fresh and 4
day old monocytes prepared by method 2 were very similar. Neither the kinetics of spontaneous
release, nor its extent at 24 hr were altered by IFN.
Cytolysis by Monocytes after various periods of cultivation in vitro
Fig. 2 indicates that the cytolytic activity (24 hr assay) during cultivation by method 2 ofmonocytes
from a single donor. At all times the cytolytic activity was enhanced in the presence of IFN. The
activity was substantial with fresh monocytes, dropped by day 3, and subsequently rose again. Fig. 2
also shows data for monocytes maintained continuously in the presence ofIFN prior to assay in the
absence of IFN. The drop and subsequent rise in cytolytic activity is qualitatively normal, although
not universal. Monocytes cultivated with IFN are at all times more active than their control
counterparts when assayed in the absence of IFN.
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Fig. 2. Cytolytic Activity of human monocytes after cultivation for various periods (up to 8 days) with or
without IFN. Cytolysis was assayed using monocytes prepared by system 2. The effector to target ratio was 10: 1
(104 K-562 targets). Monocytes were pre-cultivated in either normal conditions or in the continuous presence of
840 iu/ml of /3-IFN (which was added to the medium at each medium change). Cytolysis was then measured
either in the absence of added IFN, or with 840 iu/ml fl-IFN added. Control pre-cultivation = 0 (no addition at
cytolysis); 0 = + IFN at cytolysis; /-IFN pre-cultivation = A (no addition at cytolysis).
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Table 1. Dose-dependence of stimulation of monocyte cytolysis by IFN
Condition during cytolysis % Specific release ( s.d.)
Control 33-7 + 2-9
+42 iu/ml f3-IFN 35 0+3-1
+420 iu/ml fJ-IFN 51 0+4-1
+ 840 iu/ml P-IFN 55 0+442
+ 1,250 iu/ml a-IFN 53 2+4 1
+2,500 iu/ml x-IFN 57-9+4-6
+ 5,000 iu/ml cx-IFN 69-1+4-8
+ 12,500 iu/ml a-IFN 64-3+ 5-1
Monocytes obtained by system 2 received 104 K-562
targets, on day 8. Effector:target ratio 10: 1; cytolysis
was conducted in the presence of various concentrations
of IFN.
Dose-response and time course ofstimulation of cytolysis by interferon
Dose-responses were studied with day 1, day 4 and day 8 cells (Table 1). Responses were quite
similar, although the maximum response was obtained at different IFN concentrations
(1,000-10,000 iu/ml) with cells from different buffy coats. Fibroblast and leucocyte IFN were
comparably effective.
The time course of the cytolytic reaction itself has been described already. In order to further
characterize the kinetics of the response of monocytes to IFN, batches of cells from a single donor
were incubated with IFN for varying periods oftime (1, 4, 12, 24 or 36 hr) prior to the cytolysis assay
conducted without addition of further IFN. As shown in Fig. 3, cells pre-incubated for 24 hr or
more showed enhanced cytolytic activity, and enhancement was maximal with approximately 24 hr
pre-incubation.
Following this, the duration of enhanced cytolysis after a 24 hr pulse of fl-IFN (840 iu/ml) was
studied. After the pulse, the media were changed to normal without added IFN, and cytolysis assays
(no further addition of IFN) were performed immediately, or after 1, 2, or 4 further days of
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Fig. 3. Cytolytic activity of monocytes after various periods of exposure to P-IFN. Monocytes prepared by
system 1, were pre-incubated with 840 iu/ml. of f3-IFN for the specified period prior to a standard assay of
cytolysis in the absence of added IFN, at day 2. Effector:target ratio < 5: 1, I0V targets (K-562).
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Table 2. Inhibition by an antibody to fi-IFN of stimulation of monocyte cytolysis by fl-IFN
Measured IFN titre of medium
Normal condition during cytolysis at conclusion of cytolysis (iu/ml) % Specific release ( s.d.)
Controls < 3 30-2+ 5-0
+ 840 iu/ml fi-IFN 768 54-4+8-9
+anti-fl-IFN 12 34-3+5-4
+840 iu/ml fl-IFN +anti-fl-IFN 36 35-3+5-6
+ anti-bovine serum albumin (BSA) < 3 29-8 + 5-0
+ bovine serum albumin < 3 29-4 + 4-8
+ BSA+ anti-BSA < 3 33-2 + 5-4
+ 840 iu/ml fl-IFN + BSA+ anti-BSA 576 52-5 + 5-4
+ 6250 iu/ml a-IFN 6,144 648+ 10-9
+ 6250 iu/ml oc-IFN + anti-fl-IFN 6,144 66-2 + 10-1
Monocytes (--6 x 104) prepared by system 1 received 104 K-562 targets on dl. The media for use in the
cytolysis were pre-incubated for 1 hr before commencement of cytolysis. The antibody to fl-IFN was used
in a nominal 10-fold excess over the fl-IFN, and in the same quantity in the incubations with a-IFN.
Where indicated, BSA was added at 100 pg/ml, and its antibody at previously determined equivalence.
cultivation (media were not changed again until the cytolysis assay commenced.). Cytolytic activity
remained stimulated for at least 4 days (data not shown).
Confirmation that the stimulation of cytolysis is due to IFN: use of an inhibitory antibody
A specific antibody to human fibroblast IFN was used to neutralize the P-IFN preparation prior to
presentation to monocytes. It largely suppressed the capacity of media containing fl-IFN to
stimulate cytolysis (Table 2). In parallel, we showed that the antibody abolished the IFN activity of
the media assayable in a viral cytopathic assay (see Methods). This was shown both with media
prior to presentation in monocytes, and with those recovered from the incubation with monocytes.
Since antigen-antibody complexes (such as those resulting from the interaction of IFN with
antibodies directed against it) themselves stimulate various actions ofmononuclear phagocytes (see
Nelson, 1976; Dean, Hylton & Allison, 1979; Dean 1980) control experiments with BSA, antibodies
to BSA and with antigen-antibody complexes resulting from their combination in quantities
somewhat greater than those of IFN-anti-IFN used, were performed. These control conditions did
not affect monocyte cytolysis (Table 2). Neither antibody had significant effect on stimulation by
a-IFN. Thus the blockade by specific antibodies of the stimulation by /3-IFN preparations, provides
strong evidence that the stimulation is due to IFN itself.
Is endotoxin requiredfor the expression ofstimulation by IFN?
Several functions of monocytes require dual stimulation, either simultaneously or successively: for
instance, production and secretion of certain neutral proteinases (see Nelson, 1976). Commercial
sera and proteins normally contain relevant amounts of bacterial endotoxins, which commonly
function as co-stimulants in such systems: for instance endotoxin is required for lymphokines to
stimulate cytolysis by mouse macrophages (Taramelli, Holden & Varesio, 1980). Therefore we
investigated the possible involvement of endotoxin as a prerequisite for or synergist with
stimulation by IFN. Endotoxin is known to stimulate monocyte cytolysis (Hammerstrom, 1979b)
and this was confirmed (data not shown in detail: see Tables 3 & 4).
Firstly, monocytes were isolated and cultivated in the absence of serum and thus of exogenous
endotoxin. As shown in Table 3 with day 3 monocytes, IFN could stimulate normally even cells
cultivated without serum; this was shown also with day 1 and day 8 cells. However, the cytolysis
itself was always conducted in the presence of serum (and thus of endotoxin), since spontaneous
release was excessive in its absence. Thus secondly, polymixin B sulphate, which forms complexes
with endotoxins, blocking their activity (e.g. Boraschi & Tagliabue, 1981) was used. Under
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Table 3. Stimulation of cytolysis in monocytes pre-cultivated in serum-free conditions: lack of requirement for
endotoxin for the effect of JJ-IFN
Condition % Specific release ( s.d.)
Controls 4 3 + 07
+840 iu/ml fl-IFN 102+ 18
+ 1,680 iu/ml fl-IFN 17 8+2-8
+ I ng/ml LPS 4 1 +0 7
+1 pg/ml LPS 11 3+1-7
+ 840 iu/ml /3-IFN+1 ng/ml LPS 9-9+1-6
Monocytes prepared by system 1 were used for a standard
cytolytic assay at day 2, in the presence of various stimuli. Ten
thousand K-562 targets; effector: target ratio < 5: 1. LPS = endo-
toxin.
Table 4. Prevention of LPS stimulation of monocyte cytolysis by complex formation with polymixin B: further
evidence that LPS is not required for stimulation by fl-IFN
Cytolysis condition % Specific release ( s.d.)
Control 15 0+ 1 6
+ 1 ng/ml LPS 13-0+ 1 4
+1 pg/ml LPS 38-1+29
+ 1 pg/ml polymixin B 12 8 + 1 4
+ 10 pg/ml polymixin B 16-5 + 1 9
+*1 ng/ml LPS+ 1 ug/ml polymixin B 17 8+ 1-9
+ 1 pg/ml LPS+ 10 ,g/ml polymixin B 20 4+1 9
+ 840 iu/ml f,-IFN 39 9+442
+ 840 iu/ml ,B-IFN+ 10 pg/ml polymixin B 38-6+443
Monocytes (system 1, day 1) were used in cytolysis against 104 K-562, in
the specified conditions. The effector: target ratio was 8: 1.
conditions in which endotoxin activity on cytolysis was blocked by polymixin, added IFN was
effective as normal (Table 4). There were indications that polymixin itselfhas a stimulatory effect on
cytolysis but these were not studied closely. Thus both kinds ofexperiment indicated that endotoxin
was not a necessary collaborator for the stimulation by interferon nor was it markedly synergistic
with IFN.
The similarity of stimulation by a- and fl-IFN largely excludes the possibility that lymphokines
might be a necessary co-stimulant with IFN (since lymphokines do not contaminate fl-IFN).
DISCUSSION
Monocytes can exert both cytostatic and cytolytic effects (Vilcek et al., 1980). The latter were the
subject ofthe present work. Previous studies (Jett et al., 1980; Stanwick, Campbell & Nahima, 1980)
have also indicated that monocyte cytolysis can be stimulated by IFN, but have almost solely
concerned freshly isolated cells. The present data confirm such previous studies; reveal that cytolysis
can be effected at low monocyte: target cell ratios (>5:1); and extend the observations to
monocytes in various stages of in vitro maturation, which are shown to be stimulated similarly by
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IFN. The stimulation correlates with the known retardation of morphological maturation in
culture (Lee & Epstein, 1980). In our studies this retardation was particularly obvious in a few
experiments in which monocytes were cultivated in the presence of high (50%) concentrations of
serum, which accentuates the expansion of the control cells.
The purity of the adherent monocyte preparations makes it unlikely that the cytolysis reported
was mediated byNK cells, a non-adherent cell type. This view is further supported by the distinctive
kinetics of cytolysis, with a lag of approximately 6 hr before detectable chromium release occurs,
followed by a rate of release which allows detection within subsequent 2 hr periods (as also noted by
Horwitz et al., 1979). Most workers have not studied the kinetics systematically, although several
have noted negligible release in 4 hr assays (e.g. Jett et al., 1980). Fischer, Hubbard & Koren (1981)
reported an exception, with rapid cytolysis, using a system like system 2 herein. The reasons for this
accelerated activity are unclear.
The mechanism by which IFN stimulates cytolysis remains unknown, as largely does the
mechanism of killing by control monocytes. However, increasing evidence implies that killing
involves free radical oxygen metabolites (Nathan et al., 1979; Temple 1981), so that IFN may act on
the pathways generating such metabolites. Since mononuclear phagocytes, tumour cells and
lymphocytes can all produce IFNs, it seems likely that there are circumstances in which the
stimulation of monocyte cytolytic activity against abnormal cells can constitute an important
defence, supporting that ofNK cells. However, recent evidence has also shown conversely that IFN
may sometimes protect cells against cell-mediated lysis (Welsh et al., 1980).
Our work shows that IFN enhances monocyte cytolytic activity without the cooperation of
certain other soluble stimuli such as LPS and lymphokines. In this respect, IFN appears to have a
direct 'macrophage activating factor' (MAF) activity. Thus IFNs, whatever their cellular source or
molecular type, may be major MAF molecules, able to regulate, through their direct effects on
mononuclear phagocytes, host responses to tumours and micro-organisms. This is in agreement
with our previous finding that patients with selective defects of leucocyte IFN production suffer
from immunoblastic lymphomas, and severe persistent viral or bacterial infections (Virelizier &
Griscelli, 1980). The MAF activity of IFN should be considered in the pathogenesis and treatment
of such human diseases.
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